---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-24-000182"
form_type: "8-K"
ticker: "PDEX"
cik: "0000788920"
company_name: "PRO DEX INC"
filed_at: "2024-02-08T23:59:59+00:00"
generated_at: "2026-06-06T06:05:59.026519+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Pro-Dex Q2 sales up 12% to $12.6M but net income falls to $500K on investment losses; new buyback launched

## Summary
- Net sales increased 12% to $12.6M vs $11.3M a year ago; repair revenue from orthopedic surgical handpiece drove growth.
- Operating income decreased 32% to $777K from $1.1M, as operating expenses rose 36% to $2.0M.
- Net income was $500K ($0.14 diluted EPS) vs $2.8M ($0.75) a year ago, reflecting $40K unrealized investment loss vs $2.7M gain.
- For the six-month period, net loss was $115K ($0.03 loss) vs net income of $4.0M ($1.08) a year ago, impacted by $2.6M unrealized investment loss.
- Company announced a new stock buy-back program and is reducing inventory levels.

## SEC filing metadata
- accession: 0001079973-24-000182
- form_type: 8-K
- ticker: PDEX
- cik: 0000788920
- company_name: PRO DEX INC
- filed_at: 2024-02-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/788920/000107997324000182/0001079973-24-000182-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/788920/000107997324000182/pdex_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-24-000182
- JSON: https://secwatch.observer/filing/0001079973-24-000182.json
- Plain text: https://secwatch.observer/filing/0001079973-24-000182.txt

## Key facts
- Earnings Releases
  PRO DEX INC reported six months ended December 31, 2023 results: revenue $24.5 million, net income Net loss for the six months ended December 31, 2023, was $115,000, EPS $0.03 per diluted share.
  - Period: six months ended December 31, 2023
  - Revenue: $24.5 million
  - Net income: Net loss for the six months ended December 31, 2023, was $115,000
  - EPS: $0.03 per diluted share
  - Result: reported results
  source text: fair value, and the valuation can be highly volatile. Six Months Ended December 31, 2023 Net sales for the six months ended December 31, 2023, increased $2.2 million, or 10%, to $24.5 million from $22.4 million for the six mo nths ended December 31, 2022, due primarily to increased repair revenue from the orthopedic surgical handpiece that we sell to our
  evidence_url: https://www.sec.gov/Archives/edgar/data/788920/000107997324000182/0001079973-24-000182-index.htm
- Earnings Releases
  PRO DEX INC reported fiscal 2024 second quarter ended December 31, 2023 results: revenue $12.6 million, net income $500,000, EPS $0.14 per diluted share.
  - Period: fiscal 2024 second quarter ended December 31, 2023
  - Revenue: $12.6 million
  - Net income: $500,000
  - EPS: $0.14 per diluted share
  - Result: reported results
  source text: Net sales for the three months ended December 31, 2023, increased $1.3 million, or 12%, to $12.6 million from $11.3 million for the three months ended December 31, 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/788920/000107997324000182/0001079973-24-000182-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.